Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter?
JV (Ian) NixonDivision of Cardiology, Medical College of Virginia at Virginia Commonwealth University, Richmond VA, USAAbstract: As the numbers of completed outcomes based clinical trials evaluating the use of statin drugs for the management of cardiovascular risk continue to increase, it is clear t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2006-12-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/who-should-receive-a-statin-drug-to-lower-cardiovascular-risk-does-the-peer-reviewed-article-VHRM |